|
|
| | L-Alanine, L-cysteinylglycyl-L-leucyl-L-serylglycyl-L-leucylglycyl-L-valyl- Basic information |
| | L-Alanine, L-cysteinylglycyl-L-leucyl-L-serylglycyl-L-leucylglycyl-L-valyl- Chemical Properties |
| Boiling point | 1249.4±65.0 °C(Predicted) | | density | 1.256±0.06 g/cm3(Predicted) | | pka | 3.41±0.10(Predicted) | | Sequence | Cys-Gly-Leu-Ser-Gly-Leu-Gly-Val-Ala |
| | L-Alanine, L-cysteinylglycyl-L-leucyl-L-serylglycyl-L-leucylglycyl-L-valyl- Usage And Synthesis |
| Uses | CooP is a linear glioblastoma-targeting nonapeptide. CooP binds to the mammary-derived growth inhibitor/fatty acid binding protein 3 (FABP3) in the glioblastoma cells and its associated vasculature. CooP is used for the targeted delivery of chemotherapy and different nanoparticles[1]. | | References | [1] Abiodun Ayo, et al. Tumor-Targeting Peptides: The Functional Screen of Glioblastoma Homing Peptides to the Target Protein FABP3 (MDGI). Cancers (Basel). 2020 Jul 8;12(7):1836. DOI:10.3390/cancers12071836 |
| | L-Alanine, L-cysteinylglycyl-L-leucyl-L-serylglycyl-L-leucylglycyl-L-valyl- Preparation Products And Raw materials |
|